11.11.2014 • News

Platform Specialty Chemicals to Launch IPO

With three major acquisitions under its belt this year, Miami, Florida-based Platform Specialty Chemicals has launched a $350 million initial public offering to cover its past purchases and fund further growth.

The ipo, for which a share price has not yet been announced, will follow a $300 million offering in May of this year and a $651 million offering in October.

The Miami chemical firm's purchases during 2014 include three agrochemicals business, including Belgium's Agriphar for $300 million, Ireland-based Arysta Life Science for $3.5 billion and Chemtura AgroSolutions, a subsidiary of US chemical producer Chemtura for $1 billion.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.